Level Bio AB (FRA:4MB) OCF Margin %: -13.41% (As of Mar. 2026)


FRA:4MB Level Bio AB FRA:4MB
23 GF Score
Price €0.01
! 4 Warning Signs
View Full Analysis

What is Level Bio AB OCF Margin %?

Level Bio AB FRA:4MB +8.00% 23 OCF Margin % is -13.41% as of Mar. 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 60.29% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Level Bio AB's Cash Flow from Operations for the three months ended in Mar. 2026 was €-0.11 Mil. Level Bio AB's Revenue for the three months ended in Mar. 2026 was €0.84 Mil. Therefore, Level Bio AB's OCF Margin % for the quarter that ended in Mar. 2026 was -13.41%.

As of today, Level Bio AB's current OCF Yield % is -3.12%.

The historical rank and industry rank for Level Bio AB's OCF Margin % or its related term are showing as below:

FRA:4MB' s OCF Margin % Range Over the Past 10 Years
Min: -20.87   Med: 1.58   Max: 8.35
Current: -1.63

During the past 13 years, the highest OCF Margin % of Level Bio AB was 8.35%. The lowest was -20.87%. And the median was 1.58%.

FRA:4MB's OCF Margin % is ranked worse than
60.29% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755 vs FRA:4MB: -1.63

Level Bio AB OCF Margin % Related Terms

Level Bio AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Level Bio AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB OCF Margin % Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.69 8.36 -20.87 -17.78 2.52

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 0.53 -8.31 12.59 -13.41

FRA:4MB vs TMO, DHR, IDXX: OCF Margin % Comparison

For the Diagnostics & Research subindustry, Level Bio AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Bio AB OCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Level Bio AB's OCF Margin % falls into.


FRA:4MB
23GF Score
Level Bio AB FRA:4MB
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Level Bio AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.075/2.974
=2.52 %

Level Bio AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.112/0.835
=-13.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -13.41% mean?
Level Bio AB (FRA:4MB) has a OCF Margin % of -13.41% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #123 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 60.3%.
Is Level Bio AB's OCF Margin % too high?
Level Bio AB's current OCF Margin % is -13.41%. Based on the distribution chart, Level Bio AB ranks #123 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #123 out of 204 companies for OCF Margin %. This places Level Bio AB in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Level Bio AB and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Bio AB's current OCF Margin % is -13.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current OCF Margin % of -13.41%. The current OCF Margin % is -13.41%. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current OCF Margin % is -13.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Other Exchanges LEVBIO:Sweden
Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for FRA:4MB

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price